Korbel Gregory Alan 4
4 · Aprea Therapeutics, Inc. · Filed Aug 1, 2022
Insider Transaction Report
Form 4
Korbel Gregory Alan
VP of Business Dev't
Transactions
- Award
Stock Option (right to Buy)
2022-07-28+35,700→ 35,700 totalExercise: $1.09Exp: 2032-07-28→ Common Stock (35,700 underlying) - Award
Common Stock
2022-07-28+24,300→ 45,762 total
Footnotes (2)
- [F1]These shares represent restricted stock units which were granted on July 28, 2022, and which will vest and be settled in common stock as follows: (i) 8,100 shares on July 28, 2023, (ii) 8,100 shares on July 28, 2024 and (iii) 8,100 shares on July 28, 2025, subject to the reporting person's continued employment through and including the applicable vesting dates and subject to acceleration under certain conditions.
- [F2]Twenty-five percent of these options vest on July 28, 2023, with the remaining options vesting ratably over the following 36 months, subject to the reporting person's continued employment through and including the applicable vesting dates and subject to acceleration under certain conditions.